Back to top
more

Veeva Systems (VEEV)

(Delayed Data from NYSE)

$204.67 USD

204.67
466,941

+0.14 (0.07%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $204.53 -0.14 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (68 out of 251)

Industry: Internet - Software

Better trading starts here.

Zacks News

Masimo's (MASI) PVi Favored by New Study for Pediatric Patients

Masimo's (MASI) PVi is expected to take better treatment decisions for pediatric patients with signs of obstructive respiratory disease in the EDs.

NextGen Healthcare's (NXGN) Solutions Selected by MHHC

NextGen Healthcare's (NXGN) solutions get chosen by MHHC that can help serve the latter's rapidly growing community efficiently.

Veeva Systems (VEEV) to Post Q1 Earnings: What's in Store?

Veeva Systems' (VEEV) fiscal first-quarter results are likely to reflect a solid show by its segments and robust product portfolio.

The Zacks Analyst Blog Highlights 8x8, Duck Creek Technologies, Paycom Software and Veeva Systems

8x8, Duck Creek Technologies, Paycom Software and Veeva Systems have been included in this Analyst Blog.

Shockwave Medical's (SWAV) IVL Cleared for Use in China

Shockwave Medical's (SWAV) latest regulatory approval is expected to serve a wider patient pool.

Here's Why You Should Retain Change Healthcare (CHNG) Stock

Change Healthcare (CHNG) continues to benefit from strategic deals. However, intense competition remains a woe.

Baidu (BIDU) to Report Q1 Earnings: What's in the Offing?

Baidu's (BIDU) first-quarter results are expected to reflect the AI business's strength and gains from expanding autonomous driving efforts.

Dell Technologies (DELL) to Post Q1 Earnings: What's in Store?

Dell Technologies' (DELL) first-quarter fiscal 2023 performance is expected to reflect strong PC sales and solid growth in servers amid supply-chain constraints and higher component costs.

Ritujay Ghosh headshot

4 Stocks to Buy on Surge in Cloud Infrastructure Spending

A rapid rise in spending on cloud infrastructure services is helping companies like 8x8, Inc. (EGHT), Duck Creek Technologies, Inc. (DCT), Paycom Software, Inc. (PAYC) and Veeva Systems Inc. (VEEV).

VMware (VMW) to Report Q1 Earnings: What's in the Cards?

VMware's (VMW) first-quarter fiscal 2023 performance is likely to have benefited from a strong portfolio and an expanding partner base.

BOX Gears Up to Report Q1 Earnings: What's in the Cards?

BOX's first-quarter fiscal 2023 results are likely to reflect gains from the growing adoption of content cloud solutions. Also, growing efforts toward product innovation might have been a tailwind.

What's in the Cards for Agilent Technologies' (A) Q2 Earnings?

Agilent Technologies' (A) fiscal second-quarter results are expected to reflect portfolio strength and momentum across all segments.

PerkinElmer (PKI) Boosts Genomic Testing Portfolio With urWGS

PerkinElmer's (PKI) urWGS will improve outcomes for critically ill patients in NICUs and PICUs.

Can Veeva (VEEV) Keep the Earnings Surprise Streak Alive?

Veeva (VEEV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Hold on to DexCom (DXCM) Stock Now

DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.

BD (BDX) Introduces New Molecular Diagnostic Platform in US

BD's (BDX) new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States to aid lab technicians in prioritizing higher value work.

Here's Why You Should Retain Cooper Companies (COO) Stock Now

Cooper Companies (COO) continues to benefit from strength in its business segments.

Here's Why You Should Retain West Pharmaceutical (WST) Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

GAN Limited (GAN) Reports Q1 Loss, Tops Revenue Estimates

GAN Limited (GAN) delivered earnings and revenue surprises of 10% and 11.23%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

BD (BDX) Extends Partnership to Boost Diagnostic Blood Collection

BD (BDX) expands strategic partnership with Babson Diagnostics that will enable less invasive blood sample collection easier and patient-centric.

Here's Why You Should Hold on to Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.

Here's Why You Should Retain Intuitive Surgical (ISRG) Stock

Intuitive Surgical (ISRG) continues to gain traction from the improving adoption of the da Vince Surgical System. Higher production costs are a woe.

Ziff Davis (ZD) Misses Q1 Earnings and Revenue Estimates

Ziff Davis (ZD) delivered earnings and revenue surprises of -5.38% and 2.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AudioEye (AEYE) Reports Q1 Loss, Tops Revenue Estimates

AudioEye (AEYE) delivered earnings and revenue surprises of 25.58% and 1.77%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

QuinStreet (QNST) Misses Q3 Earnings and Revenue Estimates

QuinStreet (QNST) delivered earnings and revenue surprises of -18.18% and 1.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?